Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
29055
Description
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Keywords
Versions (5)
- 10/5/17 10/5/17 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 9/17/21 9/17/21 -
Copyright Holder
gsk
Uploaded on
February 22, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole Case Report Form GSK RRL100013
Similar models
CENTRAL LABORATORY
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date sample taken
Item
Date sample taken
date
C1302413 (UMLS CUI [1])
Start date of ECG
Item
Start date of ECG
datetime
C0808070 (UMLS CUI [1,1])
C0013798 (UMLS CUI [1,2])
C0013798 (UMLS CUI [1,2])
CL Item
Normal (1)
C0522054 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Abnormal - not clinically significant: Record on the Investigator Comments page. (2)
C0438154 (UMLS CUI-1)
C2826279 (UMLS CUI-2)
(Comment:en)
C2826279 (UMLS CUI-2)
(Comment:en)
CL Item
Abnormal - clinically significant: Complete the Non-Serious Adverse Events (AE) or Serious (3)
C0438154 (UMLS CUI-1)
C2826279 (UMLS CUI-2)
(Comment:en)
C2826279 (UMLS CUI-2)
(Comment:en)
CL Item
(4)
(Comment:en)
CL Item
(5)
(Comment:en)
Item
Change in ECG Result
integer
C0438154 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,2])
CL Item
Clinically significant change from Screening favourable (1)
CL Item
Clinically significant change from Screening unfavourable (2)
CL Item
No change or insignificant change from Screening (3)